Literature DB >> 31626288

Astrocytic Tau Deposition Is Frequent in Typical and Atypical Alzheimer Disease Presentations.

Amber Nolan1, Elisa De Paula Franca Resende1, Cathrine Petersen1, Kyra Neylan1, Salvatore Spina1, Eric Huang1, William Seeley1, Zachary Miller1, Lea T Grinberg1.   

Abstract

Typical Alzheimer disease (AD) features an amnestic syndrome that reflects the progression of pathology through specific neural networks. However, a subset of patients exhibits atypical onset with prominent language, behavioral, or visuospatial deficits that are not explained by current neuropathological staging schemes. Astrogliopathy featuring tau inclusions with thorn-shaped and granular fuzzy morphologies is common in the aging brain and collectively known as aging-related tau astrogliopathy (ARTAG). Prior studies have identified tau-positive thorn-shaped astrocytes in the white matter that associate with a primary progressive aphasia phenotype in an AD cohort. However, a possible contribution of ARTAG copathology to AD clinical heterogeneity has yet to be systematically examined. To investigate whether ARTAG pathology contributes to atypical presentations, we mapped the presence and density of ARTAG subtypes throughout cortical and subcortical regions in a well-characterized cohort of AD cases enriched for atypical presentations. In our cohort, ARTAG pathology is frequent and correlates with older age and higher Braak stage. ARTAG subtypes exhibit distinct distribution patterns with subpial and subependymal deposition occurring in the amygdala, while white and grey matter astrocytic deposition are distributed throughout cortical regions. However, ARTAG pathology is equally prevalent in cases with typical and atypical clinical presentations.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Aging-related tau astrogliopathy (ARTAG); Astrocytes; Atypical Alzheimer disease; Clinical heterogeneity; Tau

Mesh:

Substances:

Year:  2019        PMID: 31626288      PMCID: PMC7967845          DOI: 10.1093/jnen/nlz094

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  43 in total

1.  Chronic Traumatic Encephalopathy (CTE) Is Absent From a European Community-Based Aging Cohort While Cortical Aging-Related Tau Astrogliopathy (ARTAG) Is Highly Prevalent.

Authors:  Shelley L Forrest; Jillian J Kril; Stephanie Wagner; Selma Hönigschnabl; Angelika Reiner; Peter Fischer; Gabor G Kovacs
Journal:  J Neuropathol Exp Neurol       Date:  2019-05-01       Impact factor: 3.685

Review 2.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

3.  Connexin-43 and aquaporin-4 are markers of ageing-related tau astrogliopathy (ARTAG)-related astroglial response.

Authors:  G G Kovacs; A Yousef; S Kaindl; V M Lee; J Q Trojanowski
Journal:  Neuropathol Appl Neurobiol       Date:  2017-08-25       Impact factor: 8.090

4.  Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases.

Authors:  Gabor G Kovacs; John L Robinson; Sharon X Xie; Edward B Lee; Murray Grossman; David A Wolk; David J Irwin; Dan Weintraub; Christopher F Kim; Theresa Schuck; Ahmed Yousef; Stephanie T Wagner; Eunran Suh; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2017-04-01       Impact factor: 3.685

5.  Altered default mode network connectivity in Alzheimer's disease--a resting functional MRI and Bayesian network study.

Authors:  Xia Wu; Rui Li; Adam S Fleisher; Eric M Reiman; Xiaoting Guan; Yumei Zhang; Kewei Chen; Li Yao
Journal:  Hum Brain Mapp       Date:  2011-01-21       Impact factor: 5.038

6.  Aging-related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes.

Authors:  Isidro Ferrer; Meritxell Aguiló García; Irene López González; Daniela Diaz Lucena; Aina Roig Villalonga; Margarita Carmona Tech; Franc Llorens; Paula Garcia-Esparcia; Alejandra Martinez-Maldonado; Margalida Frau Mendez; Benjamín Torrejón Escribano; Joan Josep Bech-Serra; Eduard Sabido; Carolina de la Torre Gómez; José Antonio Del Rio
Journal:  Brain Pathol       Date:  2018-02-25       Impact factor: 6.508

Review 7.  Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

Authors:  J J Hauw; S E Daniel; D Dickson; D S Horoupian; K Jellinger; P L Lantos; A McKee; M Tabaton; I Litvan
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study.

Authors:  Stephen B Wharton; Thais Minett; David Drew; Gillian Forster; Fiona Matthews; Carol Brayne; Paul G Ince
Journal:  Acta Neuropathol Commun       Date:  2016-02-08       Impact factor: 7.801

View more
  9 in total

Review 1.  Genetic Insights into Alzheimer's Disease.

Authors:  Caitlin S Latimer; Katherine L Lucot; C Dirk Keene; Brenna Cholerton; Thomas J Montine
Journal:  Annu Rev Pathol       Date:  2021-01-24       Impact factor: 23.472

Review 2.  Astroglia and Tau: New Perspectives.

Authors:  Gabor G Kovacs
Journal:  Front Aging Neurosci       Date:  2020-04-09       Impact factor: 5.750

3.  A Coordinated Approach by Public Domain Bioinformatics Resources to Aid the Fight Against Alzheimer's Disease Through Expert Curation of Key Protein Targets.

Authors:  Lionel Breuza; Cecilia N Arighi; Ghislaine Argoud-Puy; Cristina Casals-Casas; Anne Estreicher; Maria Livia Famiglietti; George Georghiou; Arnaud Gos; Nadine Gruaz-Gumowski; Ursula Hinz; Nevila Hyka-Nouspikel; Barbara Kramarz; Ruth C Lovering; Yvonne Lussi; Michele Magrane; Patrick Masson; Livia Perfetto; Sylvain Poux; Milagros Rodriguez-Lopez; Christian Stoeckert; Shyamala Sundaram; Li-San Wang; Elizabeth Wu; Sandra Orchard
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP.

Authors:  Jorge J Llibre-Guerra; Suzee E Lee; Claudia K Suemoto; Alexander J Ehrenberg; Gabor G Kovacs; Anna Karydas; Adam Staffaroni; Elisa De Paula Franca Resende; Eun-Joo Kim; Ji-Hye Hwang; Eliana Marisa Ramos; Kevin J Wojta; Lorenzo Pasquini; Shirley Yin-Yu Pang; Salvatore Spina; Isabel E Allen; Joel Kramer; Bruce L Miller; William W Seeley; Lea T Grinberg
Journal:  Brain Pathol       Date:  2021-02-11       Impact factor: 6.508

Review 5.  Space-occupying brain lesions, trauma-related tau astrogliopathy, and ARTAG: a report of two cases and a literature review.

Authors:  Adam D Bachstetter; Filip G Garrett; Gregory A Jicha; Peter T Nelson
Journal:  Acta Neuropathol Commun       Date:  2021-03-23       Impact factor: 7.801

6.  DHCR24 Knockdown Induces Tau Hyperphosphorylation at Thr181, Ser199, Ser262, and Ser396 Sites via Activation of the Lipid Raft-Dependent Ras/MEK/ERK Signaling Pathway in C8D1A Astrocytes.

Authors:  Meiting Mai; Xiaorou Guo; Yue Huang; Wenbin Zhang; Yixuan Xu; Ying Zhang; Xiaojing Bai; Junfeng Wu; Hengbing Zu
Journal:  Mol Neurobiol       Date:  2022-07-08       Impact factor: 5.682

7.  Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment.

Authors:  Breton M Asken; Lawren VandeVrede; Julio C Rojas; Corrina Fonseca; Adam M Staffaroni; Fanny M Elahi; Cutter A Lindbergh; Alexandra C Apple; Michelle You; Sophia Weiner-Light; Nivetha Brathaban; Nicole Fernandes; Adam L Boxer; Bruce L Miller; Howie J Rosen; Joel H Kramer; Kaitlin B Casaletto
Journal:  J Int Neuropsychol Soc       Date:  2021-06-22       Impact factor: 3.114

8.  Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases.

Authors:  Tomoko Miki; Osamu Yokota; Takashi Haraguchi; Hideki Ishizu; Masato Hasegawa; Takeshi Ishihara; Shu-Ichi Ueno; Shintaro Takenoshita; Seishi Terada; Norihito Yamada
Journal:  Brain Pathol       Date:  2020-05-06       Impact factor: 6.508

9.  Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia.

Authors:  Sagar Gaikwad; Nicha Puangmalai; Alice Bittar; Mauro Montalbano; Stephanie Garcia; Salome McAllen; Nemil Bhatt; Minal Sonawane; Urmi Sengupta; Rakez Kayed
Journal:  Cell Rep       Date:  2021-07-20       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.